Elekta AB (publ) Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 22 Fair Values set on narratives written by author
EKTA B Community Narratives
European Launches And Chinese Recovery Will Expand Precision Radiotherapy Adoption
Rising Trade Barriers And Competition Will Squeeze MedTech Margins
Adaptive Radiotherapy And AI Convergence Will Expand Emerging Markets
European Launches And Chinese Recovery Will Expand Precision Radiotherapy Adoption
View narrativeAdaptive Radiotherapy And AI Convergence Will Expand Emerging Markets
View narrativeRising Trade Barriers And Competition Will Squeeze MedTech Margins
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
EKTA B: Future Returns Will Rely On Margin Delivery Versus Cautious Ratings
EKTA B: Transformation Progress And Cost Savings Will Support Medium Term Upside
EKTA B: Heightened Execution Risks Will Challenge Higher P E Assumptions
Snowflake Analysis
Elekta AB (publ) Key Details
- -0.91
- 39.60%
- -2.18%
- 76.7%
About EKTA B
- Founded
- 1972
- Employees
- 3996
- CEO
- Website
View website
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machines and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo, a CT-Linac solution; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Elekta Care, a personalized services for radiotherapy suites. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Elekta Geneva, an applicator for cervical cancer patients; and Elekta Xoft Axxent electronic brachytherapy systems. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning; Elekta Care Community, a self-help center; and Elekta Partner Community, an online self-service portal. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.